These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

725 related articles for article (PubMed ID: 33252480)

  • 1. Impact of rosuvastatin on atherosclerosis in people with HIV at moderate cardiovascular risk: a randomised, controlled trial.
    Trevillyan JM; Dart A; Paul E; Cavassini M; Fehr J; Staehelin C; Dewar EM; Hoy JF; Calmy A
    AIDS; 2021 Mar; 35(4):619-624. PubMed ID: 33252480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial.
    Crouse JR; Raichlen JS; Riley WA; Evans GW; Palmer MK; O'Leary DH; Grobbee DE; Bots ML;
    JAMA; 2007 Mar; 297(12):1344-53. PubMed ID: 17384434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rosuvastatin Slows Progression of Carotid Intima-Media Thickness: The METEOR-China Randomized Controlled Study.
    Zheng H; Li H; Wang Y; Li Z; Hu B; Li X; Fu L; Hu H; Nie Z; Zhao B; Wei D; Karlson BW; Bots ML; Meng X; Chen Y; Wang Y;
    Stroke; 2022 Oct; 53(10):3004-3013. PubMed ID: 36017704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measuring effects on intima-media thickness: an evaluation of rosuvastatin in Chinese subjects with subclinical atherosclerosis-design, rationale, and methodology of the METEOR-China study.
    Wang Y; Wang A; Li H; Li Z; Hu B; Li X; Zheng H; Fu L; Hu H; Nie Z; Qin Y; Zhao B; Wei D; Karlson BW; Bots ML; Chen Y; Wang Y
    Trials; 2020 Nov; 21(1):921. PubMed ID: 33176842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rosuvastatin slows progression of subclinical atherosclerosis in patients with treated HIV infection.
    Longenecker CT; Sattar A; Gilkeson R; McComsey GA
    AIDS; 2016 Sep; 30(14):2195-203. PubMed ID: 27203715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of atherosclerosis in patients living with HIV.
    De Lorenzo F; Boffito M; Collot-Teixeira S; Gazzard B; McGregor JL; Shotliff K; Xiao H
    Vasc Health Risk Manag; 2009; 5(1):287-300. PubMed ID: 19436663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does baseline carotid intima-media thickness modify the effect of rosuvastatin when compared with placebo on carotid intima-media thickness progression? The METEOR study.
    Crouse JR; Bots ML; Evans GW; Palmer MK; O'Leary DH; Grobbee DE; Raichlen JS;
    Eur J Cardiovasc Prev Rehabil; 2010 Apr; 17(2):223-9. PubMed ID: 20038840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-year treatment with rosuvastatin reduces carotid intima-media thickness in HIV type 1-infected patients receiving highly active antiretroviral therapy with asymptomatic atherosclerosis and moderate cardiovascular risk.
    Calza L; Manfredi R; Colangeli V; Trapani FF; Salvadori C; Magistrelli E; Danese I; Verucchi G; Serra C; Viale P
    AIDS Res Hum Retroviruses; 2013 Mar; 29(3):547-56. PubMed ID: 23098891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin therapy decreases N-terminal pro-B-type natriuretic peptide in HIV: randomized placebo-controlled trial.
    Dirajlal-Fargo S; Kinley B; Jiang Y; Longenecker CT; Hileman CO; Debanne S; McComsey GA
    AIDS; 2015 Jan; 29(3):313-21. PubMed ID: 25686680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline Vitamin D Deficiency Decreases the Effectiveness of Statins in HIV-Infected Adults on Antiretroviral Therapy.
    Hileman CO; Tangpricha V; Sattar A; McComsey GA
    J Acquir Immune Defic Syndr; 2017 Apr; 74(5):539-547. PubMed ID: 28045766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rosuvastatin vs. protease inhibitor switching for hypercholesterolaemia: a randomized trial.
    Lee FJ; Monteiro P; Baker D; Bloch M; Roth N; Finlayson R; Moore R; Hoy J; Martinez E; Carr A
    HIV Med; 2016 Sep; 17(8):605-14. PubMed ID: 26987376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensive lipid lowering may reduce progression of carotid atherosclerosis within 12 months of treatment: the METEOR study.
    Bots ML; Palmer MK; Dogan S; Plantinga Y; Raichlen JS; Evans GW; O'Leary DH; Grobbee DE; Crouse JR;
    J Intern Med; 2009 Jun; 265(6):698-707. PubMed ID: 19298496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short Communication: The Effect of Rosuvastatin on Vascular Disease Differs by Smoking Status in Treated HIV Infection.
    Hileman CO; McComsey GA
    AIDS Res Hum Retroviruses; 2018 Mar; 34(3):282-285. PubMed ID: 28974102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in oxidized lipids drive the improvement in monocyte activation and vascular disease after statin therapy in HIV.
    Hileman CO; Turner R; Funderburg NT; Semba RD; McComsey GA
    AIDS; 2016 Jan; 30(1):65-73. PubMed ID: 26731754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Manual or semi-automated edge detection of the maximal far wall common carotid intima-media thickness: a direct comparison.
    Peters SA; den Ruijter HM; Palmer MK; Grobbee DE; Crouse JR; O'Leary DH; Evans GW; Raichlen JS; Lind L; Bots ML;
    J Intern Med; 2012 Mar; 271(3):247-56. PubMed ID: 21726301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biologically implausible carotid intima-media thickness measurement values: effects on rate of change over time.
    Peters SA; den Ruijter HM; Palmer MK; Grobbee DE; Crouse JR; O'Leary DH; Evans GW; Raichlen JS; Bots ML;
    Curr Med Res Opin; 2012 Jun; 28(6):891-9. PubMed ID: 22536884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of insulin glargine and n-3FA on carotid intima-media thickness in people with dysglycemia at high risk for cardiovascular events: the glucose reduction and atherosclerosis continuing evaluation study (ORIGIN-GRACE).
    Lonn EM; Bosch J; Diaz R; Lopez-Jaramillo P; Ramachandran A; Hâncu N; Hanefeld M; Krum H; Ryden L; Smith S; McQueen MJ; Dyal L; Yusuf S; Gerstein HC;
    Diabetes Care; 2013 Sep; 36(9):2466-74. PubMed ID: 23564916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial.
    Preiss D; Lloyd SM; Ford I; McMurray JJ; Holman RR; Welsh P; Fisher M; Packard CJ; Sattar N
    Lancet Diabetes Endocrinol; 2014 Feb; 2(2):116-24. PubMed ID: 24622715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of 2-year treatment with low-dose rosuvastatin on intima-media thickness in hypercholesterolemic subjects with asymptomatic carotid artery disease.
    Riccioni G; Cipollone F; Santovito D; Scotti L; D'Orazio N; Mezzetti A; Bucciarelli T
    Expert Opin Pharmacother; 2011 Dec; 12(17):2599-604. PubMed ID: 21999752
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 37.